ATM $3 Party
- financial results for the 6 months ended 31 December 2015 (NZ$m)
Total revenue of $139.1 million, an increase of 86% over the prior corresponding period (pcp)
Substantial growth in sales of a2 Platinum® infant formula across Australia and New Zealand (ANZ) and
China with total revenue of $73.9 million, up 340% on pcp. This compares with previously advised sales for the four months to 31 October 2015 of $38.0 million
Net profit after tax of $10.1 million, compared to $0.1 million in pcp
Group operating EBITDA1 of $18.7 million, representing a 472% increase on pcp. This result includes
expensing establishment costs in the USA and UK markets of $8.1 million, record operating performance in ANZ and significant growth in China
Increased fresh milk performance in Australia with sales up 5% in AUD over the pcp
Accordingly, the full year forecast has been revised upward with Group revenue in the range of $335
million to $350 million and Group operating EBITDA forecast to be in the range of $45 million to $49 million"
- Forums
- ASX - By Stock
- A2M
- ATM $3 Party
ATM $3 Party
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.46 |
Change
0.110(1.73%) |
Mkt cap ! $4.677B |
Open | High | Low | Value | Volume |
$6.37 | $6.57 | $6.33 | $12.49M | 1.926M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5264 | $6.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.48 | 8 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5264 | 6.460 |
10 | 28965 | 6.450 |
3 | 31664 | 6.440 |
2 | 13893 | 6.430 |
3 | 8152 | 6.420 |
Price($) | Vol. | No. |
---|---|---|
6.480 | 8 | 1 |
6.520 | 3628 | 3 |
6.530 | 7841 | 1 |
6.540 | 11831 | 2 |
6.550 | 15457 | 8 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online